TITLE

Time for a fresh look at ROP screening

AUTHOR(S)
Fielder, A R
PUB. DATE
March 2003
SOURCE
Eye;Mar2003, Vol. 17 Issue 2, p117
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Eye (2003) 17, 117-118. doi:10.1038/sj.eye.6700297
ACCESSION #
9295634

 

Related Articles

  • Are screening, treatment guidelines for ROP too rigid? Cooney, Michael J. // Ophthalmology Times;10/15/99, Vol. 24 Issue 20, p80 

    Deals with the guidelines in the United States for screening premature infants for retinopathy of prematurity (ROP). Gestational age cut-off requirements; Common cause for litigation in cases of infants with ROP; Pieces of advice for the screening process.

  • Screening for retinopathy of prematurity (ROP) in the middle Black Sea region of Turkey. Beden, Omit; Demir, Selim; Aygün, Canan; üködük, Şükrü Küç; Erkan, Dilek // Turkish Journal of Pediatrics;May/Jun2012, Vol. 54 Issue 3, p223 

    This study was designed to determine the frequency of retinopathy of prematurity (ROP) and the effectiveness of the screening protocol in preterm infants for our country. With these objectives, the charts of 1000 preterm infants were reviewed in Ondokuz Mayıs University, Department of...

  • Ophthalmologists hold ROP diagnosis in the palm of their hand. Cowles, Carey // Ocular Surgery News Asia-Pacific;May2010, Vol. 21 Issue 3, p8 

    The article features the use of iPhones by physicians at the Narayana Nethralaya Postgraduate Institute of Ophthalmology in Bangalore, India to screen infants for retinopathy of prematurity (ROP). ROP is reportedly a major cause of infant blindness in India, with 15 to 20 percent of at-risk...

  • Nitrous oxide analgesia during retinopathy screening: a randomised controlled trial. Mandel, Romain; Ali, Nabeel; Chen, John; Galic, Ivan John; Levesque, Linda // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Mar2012, Vol. 97 Issue 2, pF83 

    Objectives To determine if the addition of an inhaled equimolar mixture of nitrous oxide (N<2>O) and oxygen (EMONO) would produce superior pain relief to standard pharmacological and non-pharmacological measures during eye examination screening for retinopathy of prematurity (ROP) in premature...

  • Importance of the 'Third Criterion' for Retinopathy of Prematurity Screening in Developing Countries. Azad, Rajvardhan; Chandra, Parijat; Patwardhan, Sourabh D.; Gupta, Aparna // Journal of Pediatric Ophthalmology & Strabismus;Nov/Dec2009, Vol. 46 Issue 6, p332 

    Purpose: Developing countries often need a modification of the American screening guidelines for retinopathy of prematurity. Methods: A total of 1,302 eyes in 651 infants with retinopathy of prematurity were analyzed by the parameters of gestational age and birth weight suggested by the American...

  • Issues Regarding the Accepted Screening Guidelines for Retinopathy of Prematurity. Wagner, Rudolph S. // Journal of Pediatric Ophthalmology & Strabismus;Nov/Dec2009, Vol. 46 Issue 6, p331 

    The author reflects on the issues concerning the accepted guidelines for screening retinopathy of prematurity (ROP) in the U.S. The disease is said to occur in infants born after 32 weeks' gestational age and whose birth weights are greater than 1,500 gram. He cites the developing countries'...

  • WINROP can modify ROP screening praxis: a validation of WINROP in populations in Sörmland and Västmanland. Eriksson, Laila; Lidén, Ulrika; Löfqvist, Chatarina; Hellström, Ann // British Journal of Ophthalmology;Jul2014, Vol. 98 Issue 7, p964 

    Background This study validates the newly developed WINROP algorithm aimed at detecting retinopathy of prematurity (ROP) requiring treatment at an early stage. The study was conducted at two middle-sized hospitals in Sweden, prospectively and retrospectively. Methods A total of 104 children...

  • New tools aid in ROP. Groves, Nancy // Ophthalmology Times;9/1/2010, Vol. 35 Issue 17, p36 

    The article reports on the benefits of FocusROP, a web-based disease management imaging system which enhances screening for retinopathy of prematurity (ROP), the leading cause of blindness in premature infants. The author mentions that the system is developed by Clarity Medical Systems. It adds...

  • Spectral-domain OCT evaluation of Nd:YAG laser treatment for Valsalva retinopathy. Sabella, Pierfilippo; Bottoni, Ferdinando; Staurenghi, Giovanni // Graefe's Archive of Clinical & Experimental Ophthalmology;Apr2010, Vol. 248 Issue 4, p599 

    To describe the spectral-domain optical coherence tomography (SD-OCT) findings in a patient with a premacular hemorrhage due to Valsalva retinopathy treated with Nd:YAG laser. Serial SD-OCT examinations were performed before and after Nd:YAG laser treatment to identify the cleavage plane of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics